Optimer Pharmaceuticals, Inc. (Nasdaq:OPTR) announced that the Compensation Committee of its Board of Directors approved the grant of inducement stock options to purchase an aggregate of 342,000 shares of common stock to 73 new employees. Optimer Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing anti-infective products worldwide. It develops products that treat […]
Trending Articles
More Pages to Explore .....